NEUROBO PHARMACEUTICALS INC (NRBO)       0.4026  -0.01 (-1.35%)

0.4026  -0.01 (-1.35%)

US64132R1077 - Common Stock - Premarket: 0.4146 +0.01 (+2.98%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2021 -0.16 -0.18 0.0212.85% Q2 2021 -0.18 -0.15 -0.03-17.65% Q1 2021 -0.15 -0.16 0.018.09% Q4 2020 -1.20 -0.19 -1.01-519.20% Q3 2020 -0.19 -0.17 -0.02-9.57% Q2 2020 -0.15 -0.19 0.0422.60% Q1 2020 -0.30 -0.10 -0.20-194.12% Q4 2019 -3.37 -0.20 -3.17-1,551.96%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.71 -0.68 -4.48%Q1 2022 -0.16 -0.15 -8.80%Q2 2022 -0.17 -0.18 3.67%Q3 2022 -0.17 -0.16 -8.38%Q4 2022 -0.19 -0.15 -26.67%FY 2023 -0.75 -0.71 -4.81%FY 2024 -0.80 -0.75 -6.91%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q4 2021 % Q4 2020 % Q3 2020 % Q2 2020 % Q1 2020 % Q4 2019 % Q2 2019 % Q4 2018 %
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 %Q4 2022 81.2M %FY 2023 %FY 2024 88.2M %